Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Hogan

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Kidney International|October 10, 2002
Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA)Jia Jin Yang, Gloria A Preston, David A Alcorta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2013
Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximabDonna O'Dell Bunch, JulieAnne G McGregor, Nirmal B Khandoobhai, et al.
Journal of the American Society of Nephrology : JASN|May 28, 2011
DRB1*15 allele is a risk factor for PR3-ANCA disease in African AmericansYali Cao, John L Schmitz, Jiajin Yang, et al.
JCI Insight|January 10, 2023
PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA diseaseDhruti P Chen, Claudia P Aiello, DeMoris McCoy, et al.
Arthritis and Rheumatism|April 5, 2013
Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell populationMeghan E Free, Donna O'Dell Bunch, Julie Anne McGregor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2015
Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitisJulieAnne G McGregor, Susan L Hogan, Elizabeth S Kotzen, et al.
British Journal of Clinical Pharmacology|March 3, 2012
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitisMelanie S Joy, Mary La, Jinzhao Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 23, 2016
Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGSLouis-Philippe Laurin, Adil M Gasim, Vimal K Derebail, et al.
Clinical Epigenetics|October 19, 2016
Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitisJiajin Yang, Heng Ge, Caroline J Poulton, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2014
Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent doseVimal K Derebail, Eduardo K Lacson, Abhijit V Kshirsagar, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Kidney International|October 10, 2002
Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA)Jia Jin Yang, Gloria A Preston, David A Alcorta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2013
Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximabDonna O'Dell Bunch, JulieAnne G McGregor, Nirmal B Khandoobhai, et al.
Journal of the American Society of Nephrology : JASN|May 28, 2011
DRB1*15 allele is a risk factor for PR3-ANCA disease in African AmericansYali Cao, John L Schmitz, Jiajin Yang, et al.
JCI Insight|January 10, 2023
PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA diseaseDhruti P Chen, Claudia P Aiello, DeMoris McCoy, et al.
Arthritis and Rheumatism|April 5, 2013
Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell populationMeghan E Free, Donna O'Dell Bunch, Julie Anne McGregor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2015
Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitisJulieAnne G McGregor, Susan L Hogan, Elizabeth S Kotzen, et al.
British Journal of Clinical Pharmacology|March 3, 2012
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitisMelanie S Joy, Mary La, Jinzhao Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 23, 2016
Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGSLouis-Philippe Laurin, Adil M Gasim, Vimal K Derebail, et al.
Clinical Epigenetics|October 19, 2016
Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitisJiajin Yang, Heng Ge, Caroline J Poulton, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2014
Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent doseVimal K Derebail, Eduardo K Lacson, Abhijit V Kshirsagar, et al.
Pageof 14